In an era where regulatory expectations, technological complexity, and global harmonization are accelerating, cross-functional excellence determines whether a device reaches patients on timeāand with the safety and performance they deserve. Organizations that treat plans as living documents, invest early in collaborative risk management, and unify engineering, clinical, regulatory, and quality perspectives transform development complexity into meaningful patient impact.

